Jayson Bedford Analyst Performance

Managing Director Medical Technology at Raymond James Financial

Jayson Bedford is a stock analyst at Raymond James Financial focused in the medical sector, covering 14 publicly traded companies. Over the past year, Jayson Bedford has issued 18 stock ratings, including strong buy and buy recommendations. While full access to Jayson Bedford's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jayson Bedford's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 38 Last 10 Years
Buy Recommendations: 94.59% 35 Buy Ratings
Companies Covered: 14 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	16.2%	6 ratings
Buy	78.4%	29 ratings
Hold	5.4%	2 ratings
Sell	0.0%	0 ratings

Out of 37 total stock ratings issued by Jayson Bedford at Raymond James Financial, the majority (78.4%) have been Buy recommendations, followed by 16.2% Strong Buy and 5.4% Hold.

Best & Worst Calls

Best Call
000.0%
HTWR
Jan 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
BAX
Feb 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	57.1% of companies on NASDAQ	8 companies
NYSE	42.9% of companies on NYSE	6 companies

Jayson Bedford, an analyst at Raymond James Financial, currently covers 14 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	92.9%
	Miscellaneous 1 company	7.1%

Jayson Bedford of Raymond James Financial specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED PRODUCTS 6 companies	42.9%
MED INSTRUMENTS 3 companies	21.4%
MED/DENTAL - SUPP 1 company	7.1%
LARGE CAP PHARMA 1 company	7.1%
MEDICAL INFO SYS 1 company	7.1%
ELECTROMEDICAL EQUIPMENT 1 company	7.1%
Miscellaneous 1 company	7.1%

About Jayson Bedford

Jayson Bedford joined Raymond James Equity Research in 2006 as a senior analyst covering medical devices. Prior to joining Raymond James, Bedford covered the medical devices sector for Adams, Harkness & Hill (now Canaccord Genuity) for more than five years. He also worked as a research associate in the sector at Advest, Inc. He has been quoted in Business Week and Investor’s Business Daily, and has been a guest speaker on CNBC. Bedford received his B.A. from Michigan State University, where he also received All-Big Ten honors, Academic All-Big Ten honors and competed in the NCAA Tennis Championship. He also holds an MBA from the University of Massachusetts at Amherst, graduating with honors.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ICUI ICU Medical	8/8/2025	Lower Price Target	$112.54	$180.00	Strong-Buy
ZBH Zimmer Biomet	8/8/2025	Boost Price Target	$98.24	$113.00	Outperform
MMSI Merit Medical Systems	7/31/2025	Lower Price Target	$83.66	$102.00	Outperform
DXCM DexCom	7/31/2025	Boost Price Target	$84.33	$102.00	Strong-Buy
BSX Boston Scientific	7/24/2025	Boost Price Target	$105.58	$124.00	Strong-Buy
BSX Boston Scientific	7/21/2025	Set Price Target	$103.85	$121.00	Strong-Buy
ABT Abbott Laboratories	7/18/2025	Lower Price Target	$124.46	$141.00	Outperform
PODD Insulet	5/27/2025	Reiterated Rating	$326.80	$360.00	Outperform
ZBH Zimmer Biomet	5/6/2025	Lower Price Target	$91.47	$104.00	Outperform
MMSI Merit Medical Systems	4/25/2025	Lower Price Target	$93.76	$108.00	Outperform
ABT Abbott Laboratories	4/17/2025	Boost Price Target	$131.84	$142.00	Outperform
JNJ Johnson & Johnson	4/14/2025	Lower Price Target	$153.67	$162.00	Outperform
PODD Insulet	2/21/2025	Reiterated Rating	$283.32	$328.00	Outperform
ZBH Zimmer Biomet	2/7/2025	Lower Price Target	$101.77	$119.00	Outperform
BSX Boston Scientific	2/6/2025	Boost Price Target	$105.29	$122.00	Strong-Buy
BSX Boston Scientific	1/31/2025	Boost Price Target	$103.16	$119.00	Strong-Buy
ISRG Intuitive Surgical	1/24/2025	Boost Price Target	$587.06	$688.00	Outperform
JNJ Johnson & Johnson	1/23/2025	Lower Price Target	$145.39	$165.00	Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.